共 50 条
- [4] Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
- [5] A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple, Intravenous, Ascending-Dose Study of Sirukumab in Patients with Cutaneous or Systemic Lupus Erythematosus. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S496 - S497
- [8] Bromocriptine in systemic lupus erythematosus: A double-blind, randomized placebo-controlled study. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1351 - 1351
- [10] Phase I, Randomized, Double-Blind, Placebo-Controlled, Multiple Intravenous, Dose-Ascending Study of Sirukumab in Cutaneous or Systemic Lupus Erythematosus ARTHRITIS AND RHEUMATISM, 2013, 65 (10): : 2661 - 2671